Navigation Links
McCulley/Cuppan Consultants Contribute Chapter to the Newly Published Book, Rhetoric of Healthcare: Essays Toward a New Disciplinary Inquiry
Date:9/13/2008

Gregory Cuppan, Managing Principal of McCulley/Cuppan and Senior Consultants, Philip Bernick and Stephen Bernhardt contributed as co-authors the chapter: "The Genre of the Clinical Study Report in Drug Development" to the newly published book: Rhetoric of Healthcare: Essays toward a New Disciplinary Inquiry. The book is a collection of essays that initiates inquiry into the role of rhetoric in various forms of healthcare and medical writing. The book is published by Hampton Press.

Salt Lake City, Utah (PRWEB) September 13, 2008 -- McCulley/Cuppan consultants contribute chapter to the newly published book: Rhetoric of Healthcare: Essays toward a New Disciplinary Inquiry.

The book is a collection of essays that initiates inquiry into the role of rhetoric in various healthcare and medical discourses and examines what rhetoric---as a discipline in its own right---can contribute.

Gregory Cuppan, Managing Principal of McCulley/Cuppan and Senior Consultants, Philip Bernick and Stephen Bernhardt contributed as co-authors the chapter: "The Genre of the Clinical Study Report in Drug Development

Rhetoric in Healthcare, the first published volume in medical rhetoric as such, brings rhetorical inquiry to the fields of medicine, health, and disease, as well as the discursive and writing modes within and about them. The chapters illustrate the wide range of topics and analytic strategies rhetoricians bring to a complex social problem. They also offer valuable new insights into several medical disciplines and the languages essential to them.

The essay by Bernick, Bernhardt, and Cuppan provides an examination of the very complex genre of the experimental clinical research report and how this writing differs from other forms of research writing.

Bernick, Bernhardt, and Cuppan were asked to contribute to this book based on their extensive experience at McCulley/Cuppan consulting to the drug industry. Collectively they have worked with over 50 pharmaceutical companies to assess, coordinate or improve the communication quality of literally hundreds of clinical research reports. http://www.mcculley-cuppan.com [McCulley/Cuppan] provides a full range of consulting, training, and writing support to the pharmaceutical R&D industry. The consulting practice is designed to help teams and companies plan and articulate document development strategies, identify issues that documents must address, and find ways to bring team intelligence to the final written products.

The book is published by Hampton Press and further details can be found on their http://www.hamptonpress.com/Merchant2/merchant.mvc?Screen=PROD&Product_Code=1-57273-790-5&Category_Code=Q308 [web site.]

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1320564.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey
2. Hollander Consultants Celebrates 25 Years as an Industry Leader in Successful Medical Practice Management Consulting
3. Employee Involvement Is Key to Long-Term Pharmacy Cost Control, Finds Buck Consultants Survey
4. Senior Healthcare Consultants and Subsidiary Companies Announce Election of Officers & Distribution Managers
5. Buck Consultants Reports Wellness Programs Are Truly Global; Objectives Vary by Region
6. Healthcare Veteran Richard Findlay Joins Diamond Management & Technology Consultants as Partner
7. Scripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer
8. Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013
9. Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year
10. Preterm Birth Contributes to Growing Number of Infant Deaths
11. Preterm birth contributes to growing number of infant deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... and safety labels , has been featured in the National Electrical ... The eiXtra e-newsletter provides electroindustry professionals with manufacturer, regulatory, and standardization news. The ...
(Date:5/24/2016)... ... 24, 2016 , ... After graduating from Cornell, author Joshua Alexander ... on medication, living on Social Security disability and staying in a group home. In ... It!” (published by Balboa Press), Alexander shares how he was finally able to heal ...
(Date:5/24/2016)... ... May 24, 2016 , ... Design Concepts , a ... del Quinto Sol Wheel Park’ in Pueblo, Colorado. This park was designed working ... special for this often overlooked neighborhood. Located at 609 E. 6th Street, Pueblo’s ...
(Date:5/24/2016)... ... 24, 2016 , ... NutraPre today announced the nationwide release ... to prevent morning sickness and promote overall heath. Engineered with advanced nanotechnology, this ... of water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO Eddie Cameron ...
(Date:5/23/2016)... ... ... to an article published May 12th on the Medical Daily, as a great ... article points out that, as long as patients are brushing as they should – twice ... course, these worn-out bristles won’t clean teeth and gum tissue as effectively, so the article ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Oregon , May 19, 2016 ... titled, World Medical/Diagnostic Imaging Market -Opportunities and Forecasts, 2015 ... reach $45.0 billion by 2022, registering a CAGR of ... expected to continue to be the highest revenue-generating segment ... accounted for around one-third of the market share ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
(Date:5/19/2016)... 2016 MGB Biopharma, a ... Anti-infectives, Welcomes the Final Instalment of Lord Jim ...   Lord Jim O,Neill,s ... recommendations, providing a comprehensive action plan for the ... rising threat of superbugs - something that could ...
Breaking Medicine Technology: